Connie A. Sizemore

T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation

Asad Bashey, Xu Zhang, Connie A. Sizemore et al. · Journal of Clinical Oncology · 2013 · 495 citations

Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial

Scott R. Solomon, Connie A. Sizemore, Melissa Sanacore et al. · Biology of Blood and Marrow Transplantation · 2012 · 296 citations · Full text

Total Body Irradiation–Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors

Scott R. Solomon, Connie A. Sizemore, Melissa Sanacore et al. · Biology of Blood and Marrow Transplantation · 2015 · 151 citations

Preemptive DLI without withdrawal of immunosuppression to promote complete donor T-cell chimerism results in favorable outcomes for high-risk older recipients of alemtuzumab-containing reduced-intensity unrelated donor allogeneic transplant: a prospective phase II trial

Scott R. Solomon, Connie A. Sizemore, X Zhang et al. · Bone Marrow Transplantation · 2014 · 42 citations

Transplant Rejection, Cell Therapy, Transplantation +12

Current Graft-versus-Host Disease–Free, Relapse-Free Survival: A Dynamic Endpoint to Better Define Efficacy after Allogenic Transplant

Scott R. Solomon, Connie A. Sizemore, Xu Zhang et al. · Biology of Blood and Marrow Transplantation · 2017 · 39 citations · Full text

Solid Organ Transplantation, Immunology, Immunotherapy +16